- Filed
- May 15, 2023 12:00 AM ET
- Period of report
- —
Restated figures. One or more values in this filing restate previously reported amounts.
On SEC.gov
Financials in this filing
| Metric | Period | Value |
|---|---|---|
| Shares Outstanding | Q1 2023 · May 2, 2023 | 21.32M sh |
| Shares Diluted | Q1 2023 · Mar 31, 2023 | 21.36M sh |
| Shares Diluted restated | Q1 2023 · Mar 31, 2022 | 22.6M sh |
| Capex | Q1 2023 · Mar 31, 2023 | $25K |
| Capex | Q1 2023 · Mar 31, 2022 | $151K |
| Operating Cash Flow | Q1 2023 · Mar 31, 2023 | −$1.01M |
| Operating Cash Flow | Q1 2023 · Mar 31, 2022 | −$3.58M |
| Cash And Equivalents | Q1 2023 · Mar 31, 2023 | $19.56M |
| Cash And Equivalents | Q1 2023 · Dec 31, 2022 | $20.71M |
| Stockholders Equity | Q1 2023 · Mar 31, 2023 | $40.09M |
| Stockholders Equity | Q1 2023 · Dec 31, 2022 | $41.04M |
| Stockholders Equity | Q1 2023 · Mar 31, 2022 | $39.02M |
| Stockholders Equity | Q1 2023 · Dec 31, 2021 | $28.62M |
| Current Liabilities | Q1 2023 · Mar 31, 2023 | $3.94M |
| Current Liabilities | Q1 2023 · Dec 31, 2022 | $3.55M |
| Current Assets | Q1 2023 · Mar 31, 2023 | $31.84M |
| Current Assets | Q1 2023 · Dec 31, 2022 | $32.24M |
| Total Assets | Q1 2023 · Mar 31, 2023 | $44.38M |
| Total Assets | Q1 2023 · Dec 31, 2022 | $44.97M |
| Eps Diluted | Q1 2023 · Mar 31, 2023 | −$0.04 |
| Eps Diluted restated | Q1 2023 · Mar 31, 2022 | $0.45 |
| Eps Basic | Q1 2023 · Mar 31, 2023 | −$0.04 |
| Eps Basic | Q1 2023 · Mar 31, 2022 | $0.45 |
| Sga Expense | Q1 2023 · Mar 31, 2023 | $2.88M |
| Sga Expense restated | Q1 2023 · Mar 31, 2022 | $2.8M |
| Rd Expense | Q1 2023 · Mar 31, 2023 | $409K |
| Rd Expense restated | Q1 2023 · Mar 31, 2022 | $495K |
| Net Income | Q1 2023 · Mar 31, 2023 | −$941K |
| Net Income | Q1 2023 · Mar 31, 2022 | $10.2M |
| Operating Income | Q1 2023 · Mar 31, 2023 | −$1.38M |
| Operating Income restated | Q1 2023 · Mar 31, 2022 | −$778K |
| Gross Profit | Q1 2023 · Mar 31, 2023 | $2.95M |
| Gross Profit restated | Q1 2023 · Mar 31, 2022 | $3.51M |
| Cost Of Revenue | Q1 2023 · Mar 31, 2023 | $2.23M |
| Cost Of Revenue restated | Q1 2023 · Mar 31, 2022 | $2.55M |
| Revenue | Q1 2023 · Mar 31, 2023 | $5.18M |
| Revenue restated | Q1 2023 · Mar 31, 2022 | $6.06M |